Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study

Critical Care Medicine

Volumn 27, Issue 4, 1999, Pages 723-732

  Briegel, Josef ^a   Forst, Helmuth ^a   Haller, Mathias ^a   Schelling, Gustav ^a   Kilger, Erich ^a   Kuprat, Gerrit ^a   Hemmer, Barbara ^a   Hummel, Theresia ^a   Lenhart, Andreas ^a   Heyduck, Mathias ^a   Stoll, Christian ^a   Peter, Klaus ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Catecho lamines; Glucocorticoids; Hemodynamics; Hydrocortisone; Hypotension; Multiple organ failure; Sepsis; Shock, septic

Indexed keywords

GLUCOCORTICOID; HYDROCORTISONE; PLACEBO;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMODYNAMIC PARAMETERS; HIGH OUTPUT HEART FAILURE; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; LIVER TOXICITY; MALE; MULTIPLE ORGAN FAILURE; NEPHROTOXICITY; PRESSOR RESPONSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SEPTIC SHOCK; TREATMENT OUTCOME;

ADULT; ANTI-INFLAMMATORY AGENTS; CARDIOTONIC AGENTS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYDROCORTISONE; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SHOCK, SEPTIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 0032946372     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199904000-00025     Document Type: Article

References (55)

1. Bennett IL Jr, Finland M, Hamburger M, et al: The effectiveness of hydrocortisone in the management of severe infections. JAMA 1963; 183:462-465
2. Sprung CL, Caralis PV, Marcial EH, et al: The effects of high-dose corticosteroids in patients with septic shock. N Engl J Med 1984; 311:1137-1143
3. The Veterans Administration Systemic Sepsis Cooperative Study Group: Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 1987; 317:659-665
4. Bone RC, Fisher CJ Jr, Clemmer TP, et al: A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987; 317:653-658
5. Cronin L, Cook DJ, Carlet J, et al: Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature. Crit Care Med 1995; 23: 1430-1439
6. Munck A, Guyre PM, Holbrook NJ: Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 1984; 5:25-44
7. Melby JC, Egdahl RH, Spink WW: Secretion and metabolism of cortisol after injection of endotoxin. J Lab Clin Med 1960; 56:50-62
8. Sibbald WJ, Short A, Cohen MP, et al: Variations in adrenocortical responsiveness during severe bacterial infections. Ann Surg 1977; 186:29-33
9. Jurney TH, Cockrell JL, Lindberg JS, et al: Spectrum of serum cortisol response to ACTH in ICU patients. Chest 1987; 92:292-295
10. Rothwell PW, Udwadia ZF, Lawler PG: Cortisol response to corticotropin and survival in septic shock. Lancet 1991; 337:582-583
11. Moran JL, Chapman MJ, O'Fathartaigh MS, et al: Hypocortisolaemia and adrenocortical responsiveness at onset of septic shock. Intensive Care Med 1994; 20:489-495
12. Bouachour G, Tirot P, Gouello JP, et al: Adrenocortical function during septic shock. Intensive Care Med 1995; 21:57-62
13. Soni A, Pepper GM, Wyrwinski PM, et al: Adrenal insufficiency occurring during septic shock: Incidence, outcome, and relationship to peripheral cytokine levels. Am J Med 1995; 98:266-271
14. Tayek JA, Atienza VJ: Pituitary-adrenal axis function in systemic inflammatory response syndrome. Endocrine 1995; 3:315-318
15. Baldwin WA, Allo M: Occult hypoadrenalism in critically ill patients. Arch Surg 1993; 128:673-676
16. Annane D, Raphael JC, Gajdos P: Steroid replacement in sepsis: An unexplored side of a multifaceted drug class. Crit Care Med 1996; 24:899-900
17. Thomas JP, El-Shaboury AH: Aldosterone secretion in steroid-treated patients with adrenal suppression. Lancet 1971; i:623-625
18. Briegel J, Forst H, Hellinger H, et al: Contribution of cortisol deficiency to septic shock. Lancet 1991; 338:507-508
19. Schneider AJ, Voerman HJ: Abrupt hemodynamic improvement in late septic shock with physiological doses of glucocorticoids. Intensive Care Med 1991; 17:436-437
20. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
21. Knaus WA, Wagner DP, Draper EA, et al: The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100:1619-1639
22. Le Gall J-R, Lemeshow S, Saulnier F: A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957-2963
23. Packman MI, Rackow EC: Optimum left heart filling pressure during fluid resuscitation of patients with hypovolemic and septic shock. Crit Care Med 1983; 11:165-169
24. Martin C, Papazian L, Perrin G, et al: Norepinephrine or dopamine for the treatment of hyperdynamic septic shock. Chest 1993; 103:1826-1831
25. Schaer GL, Fink MP, Parrillo JE: Norepinephrine alone versus norepinephrine plus low-dose dopamine: Enhanced renal blood flow with combination pressor therapy. Crit Care Med 1985; 13:492-496
26. Quezado ZMN, Natanson C: Systemic hemodynamic abnormalities and vasopressor therapy in sepsis and septic shock. Am J Kidney Dis 1992; 20: 214-222
27. Unertl K, Ruckdeschel G, Selbmann HK, et al: Prevention of colonization and respiratory infections in long-term ventilated patients by local antimicrobial prophylaxis. Intensive Care Med 1987; 13:106-113
28. Schedel I, Dreikhausen U, Nentwig B, et al: Treatment of Gram-negative septic shock with an immunoglobulin preparation: A prospective, randomized clinical trial. Crit Care Med 1991; 19:1104-1113
29. O'Quin R, Marini JJ: Pulmonary artery occlusion pressure: Clinical physiology, measurement, and interpretation. Am Rev Respir Dis 1983; 128: 319-326
30. Bastos PG, Sun X, Wagner DP, et al: Glasgow Coma Scale score in the evaluation of outcome in the intensive care unit: Findings from the Acute Physiology and Chronic Health Evaluation III study. Crit Care Med 1993; 21: 1459-1465
31. Vincent JL, Moreno R, Willatts S, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996; 22:707-710
32. Slotman GJ, Fisher CJ Jr, Bone RC, et al: Detrimental effects of high-dose methylprednisolone sodium succinate on serum concentrations of hepatic and renal function indicators in severe sepsis and septic shock. Crit Care Med 1993; 21:191-195
33. Weissman C: The metabolic response to stress: An overview and update. Anesthesiology 1990; 73:308-327
34. Rizza RA, Mandarino LJ, Gerich JE: Cortisol-induced insulin resistance in man: Impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J Clin Endocrinol Metab 1982; 54:131-138
35. Matthews JN, Altman DG, Campbell MJ, et al: Analysis of serial measurements in medical research. BMJ 1990; 300:230-235
36. Bone RC, Fisher CJ Jr, Clemmer TP, et al: Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest 1987; 92:1032-1036
37. Bernard C, Tedgui A: Cytokine network and the vessel wall. Insights into septic shock pathogenesis. Eur Cytokine Netw 1992; 3:19-33
38. Suba EA, McKenna TM, Williams TJ: In vivo and in vitro effects of endotoxin on vascular responsiveness to norepinephrine and signal transduction in the rat. Circ Shock 1992; 36:127-133
39. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329:2002-2012
40. Parrillo JE: Mechanisms of disease: Pathogenetic mechanisms of septic shock. N Engl J Med 1993; 328:1471-1477
41. Palmer RMJ: The discovery of nitric oxide in the vessel wall: A unifying concept in the pathogenesis of sepsis. Arch Surg 1993; 128:396-401
42. Gómez-Jiménez J, Salgado A, Mourelle M, et al: L-arginine: Nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 1995; 23:253-258
43. Landin L, Lorente JA, Renes E, et al: Inhibition of nitric oxide synthesis improves the vasoconstrictive effect of noradrenaline in sepsis. Chest 1994; 106:250-256
44. Petros A, Lamb G, Leone A, et al: Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 1994; 28:34-39
45. Radomski MW, Palmer RMJ, Moncada S: Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci U S A 1990; 87:10,043-10,047
46. Warren JB, Coughlan ML, Williams TJ: Endotoxin-induced vasodilatation in anaesthetized rat skin involves nitric oxide and prostaglandin synthesis. Br J Pharmacol 1992; 106:953-957
47. Hinshaw LB: High-dose corticosteroids in the critically ill patient. Current concept and future developments. Acta Chir Scand Suppl 1985; 526:129-137
48. Motsay GJ, Dietzman RH, Ersek RA, et al: Hemodynamic alterations and results of treatment in patients with Gram-negative septic shock. Surgery 1970; 67:577-583
49. Clore J, Schoolwerth A, Watlington CO: When is cortisol a mineralocorticoid. Kidney Int 1992; 42:1297-1308
50. Parker MM, McCarthy KE, Ognibene FP, et al: Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 1990; 97:126-131
51. Briegel J, Kellermann W, Forst H, et al: Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. Clin Invest 1994; 72:782-787
52. Parker MM, Shelhamer JH, Natanson C, et al: Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: Heart rate as an early predictor of prognosis. Crit Care Med 1987; 15:923-929
53. Metrangolo L, Fiorillo M, Friedman G, et al: Early hemodynamic course of septic shock. Crit Care Med 1995; 23: 1971-1975
54. Meduri GU, Headley S, Golden E, et al: Methylprednisolone treatment (MPT) of unresolving ARDS. Abstr. Shock 1997; 7:A664
55. Meduri GU, Cinn AJ, Leeper KV, et al: Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Patterns of response and predictors of outcome. Chest 1994; 105:1516-1527